Biotech Startups

Syndeio Biosciences (Gate Neurosciences) is a synapse-focused biotech developing drug candidates for neuropsychiatric, mental health, and cognitive disorders such as depression, Alzheimer's, and schizophrenia. Its pipeline includes NMDA-receptor positive allosteric modulators like zelquistinel and apimostinel, supported by a proprietary synapse pharmacology platform originating from a Stanford University laboratory.

1 investor

Gavi is a public-private partnership that funds vaccination programs in developing countries through contributions from governments, foundations, corporations, and private donors. The organization mobilizes resources to provide vaccine access and shape vaccine markets in supported nations.

1 investor

Galaxy Brain Scientific develops personalized brain mapping and neuromodulation technologies for research and clinical applications across neurological conditions. The company combines proprietary platform technology for individual brain functional mapping with a non-invasive stimulation system to support precision neuroscience research.

1 investor

GBI Biomanufacturing manufactures stem cells for regenerative medicine applications, including treatments for orthopedic injuries, wound care, and arthritic conditions. The company operates a 40,000-square-foot facility in Plantation, Florida and has expanded its stem-cell production capacity to serve growing demand driven by new state legislation permitting broader clinical use of stem-cell therapies.

1 investor

GCS develops advanced biomaterials through proprietary technologies including silk-fibroin fusion materials, RNA hydrogels, and ion-engineered PLLA for scalable real-world applications. The company operates at the intersection of scientific discovery and materials innovation.

1 investor

A South Korean developer of biopharmaceutical products for veterinary use, focused on animal health and welfare through innovative drug development and biopharmaceutical research.

1 investor

Gearbox Biosciences develops Pop-Out-Plasmid (POP) technology, an E. coli platform that produces plasmid DNA and recombinant proteins without antibiotic selection markers or chemical inducers like IPTG, while decoupling growth from production. Its products serve biopharma partners in gene therapy, cell therapy, and vaccine manufacturing, and the technology is available for licensing.

1 investor

Gedea Biotech develops pHyph, an antibiotic-free treatment for bacterial vaginosis and other common vaginal infections aimed at supporting a healthy microbiome. A spin-out from Lund University, the company focuses on women's health and is pursuing partnerships and regulatory approvals in Europe and the US.

1 investor

GEM Biosciences develops therapeutics based on the health benefits of carbon monoxide, including an application branded Sports CO-GEM.

1 investor

Gemelli Biotech develops clinically validated at-home gastrointestinal diagnostic tests, including breath and blood tests, to help patients and clinicians identify the root causes of gut symptoms such as SIBO and post-infectious IBS. Its tests were developed in partnership with the MAST Program at Cedars-Sinai and are used by both consumers and hospitals/clinics.

1 investor

Developer of the Golden Halo, a medical device using electromagnetic fields to non-invasively reprogram cancer cell metabolism.

1 investor

GEMMABio is a biotechnology company developing gene therapies for rare diseases using next-generation AAV technology, with programs spanning motor neuron disorders and skeletal and cardiomyopathies. It focuses on making treatments accessible to patients globally, with an emphasis on the rare disease community.

1 investor

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.

1 investor

GenAIRx develops AI technology to accelerate the discovery and development of specialty medicines. The company serves pharmaceutical and biotech organizations seeking to improve drug development timelines and outcomes.

1 investor

Genascence develops gene therapy treatments for musculoskeletal diseases, with a focus on osteoarthritis. It aims to apply gene therapy to highly prevalent conditions rather than only rare disorders.

1 investor

Genase Therapeutics is a biotech company developing cancer therapies that target metabolic vulnerabilities in oncogene-addicted cancers. Its team has prior experience advancing oncology drugs from preclinical stage to market.

1 investor

Genbioma develops clinically validated postbiotic ingredients derived from gut microbiome science to support metabolic balance, intended for food, beverage, and nutraceutical formulations. It uses proprietary research, AI-driven discovery, and in vivo validation, working with hospitals, universities, and research centers to build clinical evidence.

1 investor

GenBody manufactures rapid diagnostic test kits, fluorescence immunoassay kits, and analysis equipment for human and veterinary use, including tests for infectious diseases, drug screening, and chronic conditions. The company also produces laboratory animals for research purposes.

1 investor

GenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.

1 investor

Gene Solutions is a biotechnology company that develops genetic testing solutions using Next-Generation Sequencing and artificial intelligence for reproductive health, clinical oncology, and multi-cancer screening. The company serves healthcare providers and patients seeking precision medicine through advanced genomic profiling and early cancer detection.

1 investor

Gene BioSystems manufactures ready-to-use qPCR reagent kits for quantitative PCR analysis across major real-time PCR systems. The products are designed for research laboratories and diagnostic facilities requiring molecular biology testing reagents.

1 investor

A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types. The company develops molecular signatures and liquid biopsy solutions for biopharma, diagnostics, and CRO partners.

1 investor

GeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.

1 investor

GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.

1 investor